Natasha Mithal

Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer

Gianmarco Leone, Francesco Orlando, Peter Dutey‐Magni, Osvaldas Vainauskas et autres

gb, it (code pays fourni par la source)

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook, Howard Kynaston et autres

gb, ca, dk (code pays fourni par la source)

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

Helena Earl, Louise Hiller, Anne-Laure Vallier, Shrushma Loi et autres

gb, ch, ca (code pays fourni par la source)

Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial

Galina Velikova, Linda Williams, Sarah Willis, J. Michael Dixon et autres

gb, nl (code pays fourni par la source)

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

Joseph Gligorov, Beyhan Ataseven, Mark Verrill, Michelino De Laurentiis et autres

fr, de, it, kr, Égypte, ch, us (code pays fourni par la source)

Abstract OT1-03-12: MANTA: A randomized phase II study of fulvestrant in combination with the dual mTOR inhibitor AZD2014 or everolimus or fulvestrant alone in estrogen receptor-positive advanced or metastatic breast cancer

P. Schmid, Maria do Céu Ferreira, Suparna Dubey, Catherine Harper‐Wynne et autres

gb (code pays fourni par la source)

A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer

Peter Hoskin, Santhanam Sundar, Krystyna Reczko, Sharon Forsyth et autres

gb (code pays fourni par la source)

Retrospective Study of the Use of Everolimus/Exemestane in the Treatment of Oestrogen Receptor Positive (ER+) Metastatic Breast Cancer (MBC): The Kent Oncology Network Experience

Joo Ern Ang, R. Jyothirmayi, Natasha Mithal, Charlotte Abson et autres

gb (code pays fourni par la source)

A Retrospective Analysis of Palliative Radiotherapy For Bone Metastasis-related Symptoms in Prostate Cancer and Whether Increased Use of Zoledronic Acid and Abiraterone has Affected the Number and Type of Treatments Given

Thomas G. Bird, Natasha Mithal

gb (code pays fourni par la source)

A Multicentre Randomised Trial of Ibandronate Compared to Single Dose Radiotherapy for Localised Metastatic Bone Pain in Prostate Cancer (RIB)

Peter Hoskin, Santhanam Sundar, Krystyna Reczko, Sharon Forsyth et autres

Alcohol Intoxication with the New Formulation of Docetaxel

Aram J. Mirza, Natasha Mithal

gb (code pays fourni par la source)

A multi-centre randomised phase III trial of Dexamethasone vs Dexamethasone and diethylstilbestrol in castration-resistant prostate cancer: immediate vs deferred Diethylstilbestrol

Jonathan Shamash, Thomas Powles, Shah Jalal Sarker, Andrew Protheroe et autres

gb (code pays fourni par la source)